Skip to main content

Advertisement

SpringerLink
Log in

Morbidity and mortality in children with anemia at initiation of dialysis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Studies in adult dialysis patients have identified anemia as a risk factor for patient morbidity and mortality. Limited comparable outcome data are available from children. We used the database from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) to identify patients <18 years of age who initiated dialysis (hemodialysis and peritoneal dialysis) between 1992 and 2001 with no prior history of dialysis or transplantation. A Cox proportional hazards model was used to evaluate the association between anemia (hematocrit <33%) at 30 days post initiation of dialysis and patient mortality. The association between anemia and prolonged hospitalization was also evaluated. Of the 1,942 patients (male 56%), 68% were anemic on day 30. One hundred and seventy-one patient deaths were reported over the 9-year observation period. The multivariate analysis demonstrated anemia to be associated with a 52% higher risk of death (adjusted relative risk 1.52, 95% confidence interval 1.03–2.26, P=0.037). Cardiopulmonary disease was the primary reported cause of death associated with anemia, accounting for 22% of cases. The presence of anemia was also associated with an increased risk for prolonged hospitalization, irrespective of dialysis modality. In conclusion, the presence of anemia 1 month after initiation of dialysis iis associated with an increased risk of prolonged hospitalization and death in pediatric patients. Further studies should ascertain whether anemia per se increases the risk of death or whether it is a marker for other conditions that shorten patient survival, such as chronic inflammation or recurrent infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. (2002) The anemia of chronic renal insufficiency (CRI). United Resource Networks, Minneapolis, Minn.

  2. Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer R, Obrador GT, Pereira BJ (2001) Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 38:803–812

    CAS  PubMed  Google Scholar 

  3. Obrador GT, Arora P, Kausz AT, Pereira BJ (1998) Pre-end-stage renal disease care in the United States: a state of disrepair. J Am Soc Nephrol 9:S44–S54

    CAS  PubMed  Google Scholar 

  4. Obrador GT, Roberts T, St. Peter WL, Frazier E, Pereira BJG, Collins AJ (2001) Trends in anemia at initiation of dialysis in the United States. Kidney Int 60:1875–1884

    Article  CAS  PubMed  Google Scholar 

  5. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ (1999) Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10:1793–1800

    CAS  PubMed  Google Scholar 

  6. Collins AJ, Ma JZ, Ebben J (2000) Impact of hematocrit on morbidity and mortality. Semin Dial 20:345–349

    CAS  Google Scholar 

  7. Eknoyan G (2001) The importance of early treatment of the anaemia of chronic kidney disease. Nephrol Dial Transplant 16:45–49

    Article  CAS  Google Scholar 

  8. Gerson A, Fivush BA, Kaskel F, Weiss L, Powe NR, Furth SL (2001) Functional outcome in adolescents with renal failure: assessing a generic health status questionnaire. Perit Dial Int 21:S89

    PubMed  Google Scholar 

  9. Kausz AT, Obrador GT, Pereira BJG (2000) Anemia management in patients with chronic renal insufficiency. Am J Kidney Dis 36:S39–S51

    CAS  PubMed  Google Scholar 

  10. Macdougall IC (2000) How to improve survival in pre-dialysis patients. Nephron 85:15–22

    Article  CAS  PubMed  Google Scholar 

  11. Moreno F, Aracil F, Pérez R, Valderrábano F (1996) Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease—related anemia with erythropoietin. Am J Kidney Dis 27:548–556

    CAS  PubMed  Google Scholar 

  12. Painter P, Moore G, Carlson L, Paul S, Myll J, Phillips W, Haskell W (2002) Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am J Kidney Dis 39:257–265

    PubMed  Google Scholar 

  13. Pattaragarn A, Warady BA, Sabath RJ, Reece M (2002) Exercise capacity in children with end-stage renal disease. Perit Dial Int 22:S74

    Google Scholar 

  14. Pereira BJ (2000) Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57:351–365

    Article  CAS  PubMed  Google Scholar 

  15. Revicki D, Brown R, Feeny D, Henry D, Teehan B, Rudnick M, Benz R (1995) Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25:548–554

    CAS  PubMed  Google Scholar 

  16. Warady BA, Jabs K (1995) New hormones in the therapeutic arsenal of chronic renal failure: growth hormone and erythropoietin. Pediatr Clin North Am 42:1551–1577

    CAS  PubMed  Google Scholar 

  17. Warady BA, Sabath RJ, Smith CA, Alon U, Hellerstein S (1991) Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol 5:718–723

    CAS  PubMed  Google Scholar 

  18. Ma JZ, Ebben J, Xia H, Collins AJ (1999) Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10:610–619

    CAS  PubMed  Google Scholar 

  19. Xia H, Ebben J, Ma JZ, Collins AJ (1999) Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 10:1309–1316

    CAS  PubMed  Google Scholar 

  20. (1997) NKF DOQI clinical practice guidelines for the treatment of chronic kidney failure. Am J Kidney Dis 30 [Suppl 3]:S192–S240

  21. Jabs K, Warady BA (1999) The impact of the Dialysis Outcomes Quality Initiative Guidelines on the care of the pediatric end-stage renal disease patient. Adv Ren Replace Ther 6:97–106

    CAS  PubMed  Google Scholar 

  22. NKF-K/DOQI (2001) Clinical practice guidelines for the treatment of anemia of chronic kidney disease. National Kidney Foundation, New York, pp 33–49

  23. (2001) United States Renal Data System's 2000 Annual Data Report. Am J Kidney Dis 38:S107–S116

    PubMed  Google Scholar 

  24. Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol 17:656–663

    Article  PubMed  Google Scholar 

  25. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73–78

    CAS  PubMed  Google Scholar 

  26. Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250–256

    CAS  PubMed  Google Scholar 

  27. Marsh JT, Brown WS, Wolcott D, Carr CR, Harper R, Schweitzer SV, Nissenson AR (1991) rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 39:155–163

    CAS  PubMed  Google Scholar 

  28. Metry G, Wikström B, Valind S, Sandhagen B, Linde T, Beshara S, Långström B, Danielson B (1999) Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol 10:854–863

    CAS  PubMed  Google Scholar 

  29. Pascual J, Teruel JL, Molla JL, Liano F, Jimenez-Mena M, Ortuno J (1991) Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 35:280–287

    CAS  PubMed  Google Scholar 

  30. Stivelman JC (2000) Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant 15:29–35

    Article  Google Scholar 

  31. Eschbach JW, Abdulhadi MBJ, Delano B, Downing M, Egrie J, Lundin A, Nissenson A, Ogden D, Paganini E, Rader B, Rutsky E, Stivelman J, Stone W, Teschan P, Van Stone J, Van Wyck D, Zuckerman K, Adamson J (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111:992–1000

    CAS  PubMed  Google Scholar 

  32. Lerner GR, Warady BA, Sullivan EK, Alexander SR (1999) Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 13:404–417

    PubMed  Google Scholar 

  33. Pereira BJG (2001) The renal anemia management period (RAMP): a proactive approach to managing the anemia of chronic kidney disease. Contemp Dial Nephrol :41–47

    Google Scholar 

  34. Collins AJ (2002) Influence of target hemoglobin in dialysis patients on morbidity and mortality. Kidney Int 61:S44–S48

    Article  Google Scholar 

  35. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119

    CAS  PubMed  Google Scholar 

  36. Ismail N, Becker BN (1998) An opportunity to intervene: erythropoietin for the treatment of anaemia in pre-dialysis patients. Nephrol Dial Transplant 13:14–17

    Article  CAS  PubMed  Google Scholar 

  37. Levin A (1999) How should anaemia be managed in pre-dialysis patients? Nephrol Dial Transplant 14:66–74

    Google Scholar 

  38. Levin A (2002) Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int 61:535–538

    Article  Google Scholar 

  39. Murphy ST, Parfrey PS (2000) The impact of anemia correction on cardiovascular disease in end-stage renal disease. Semin Nephrol 20:350–355

    CAS  PubMed  Google Scholar 

  40. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318–323

    Article  CAS  PubMed  Google Scholar 

  41. Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648–653

    Article  PubMed  Google Scholar 

  42. Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191–197

    Article  CAS  PubMed  Google Scholar 

  43. Muirhead N, Hodsman AB (1990) Occult infection and resistance of anaemia to rHuEpo therapy in renal failure. Nephrol Dial Transplant 5:232–234

    CAS  PubMed  Google Scholar 

  44. Bellizzi V (2002) Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40:549–555

    Article  CAS  PubMed  Google Scholar 

  45. Frankenfield M, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA (2002) Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17:10–15

    Article  PubMed  Google Scholar 

  46. Stevens L, Stigant C, Levin A (2002) Should hemoglobin be normalized in patients with chronic kidney disease? Semin Dial 15:8–13

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children's Mercy Hospital, Kansas City, Missouri, MO 64108, USA

    Bradley A. Warady

  2. EMMES Corporation, 401 N. Washington Street, Rockville, MD 20850, USA

    Martin Ho

Authors
  1. Bradley A. Warady
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bradley A. Warady.

Additional information

A Report of the North American Pediatric Renal Transplant Cooperative Study

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warady, B.A., Ho, M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18, 1055–1062 (2003). https://doi.org/10.1007/s00467-003-1214-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1214-1

Keywords

Search

Navigation